Algo version: 0.98b
Consun Pharmaceutical is listed at the HKSE Exchange
Consun Pharmaceutical [1681.HK]
HKSE Sector: Pharmaceuticals Industry:Drug Manufacturers—Specialty & Generic

Is Consun Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Consun Pharmaceutical pays dividends. Last time was Friday 20th of September 2024 where the investors holding the stock on Thursday 5th of September 2024 were paid HKD0.3 per share. Over the last 22 times between 2014 and 2024, Consun Pharmaceutical has paid HKD2.99057 with an average of HKD0.14 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Consun Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD4.71, you would have made a profit of HKD0.690 per share or 14.65%

Yes, the average daily trading liquidity for Consun Pharmaceutical is HKD3.13 million. You should therefore be able to get in and out of your positions relatively fast.

Consun Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.60, the company's ability to pay off the debt is good. Consun Pharmaceutical has a very good net profit margin of 30.29% and should have very high tolerances against inflation.

We have calculated the inflation risk for Consun Pharmaceutical to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.